Lisinopril protects against the adriamycin nephropathy and reverses the renalase reduction: Potential role of renalase in adriamycin nephropathy

Kidney and Blood Pressure Research

Volumn 37, Issue 4-5, 2013, Pages 295-304

  Han, Pengxun ^a   Sun, Huili ^a   Xu, Yuanzhao ^a   Zeng, Youjia ^a   Yi, Wuyong ^a   Wu, Jia ^a   Shao, Mumin ^a   Li, Shunmin ^a   Yi, Tiegang ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Adriamycin nephropathy; Blood pressure; Lisinopril; Renalase

Indexed keywords

DOXORUBICIN; ENZYME; LISINOPRIL; RENALASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; ENZYMURIA; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DOXORUBICIN; KIDNEY DISEASES; LISINOPRIL; MALE; MONOAMINE OXIDASE; RATS; RATS, WISTAR;

EID: 84890407766     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000350157     Document Type: Article

References (31)

1. Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005; 115: 1275-1280
2. Desir GV. Renalase is a novel renal hormone that regulates cardiovascular function. J Am Soc Hypertens 2007; 1: 99-103
3. Wang F, Xing T, Li J, Bai M, Hu R, Zhao Z, Tian S, Zhang Z, Wang N. Renalase's expression and distribution in renal tissue and cells. PLoS One 2012; 7: e46442
4. Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, Desir GV. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 2008; 117: 1277-1282
5. Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P, Wang L, Hu D, Huang J, Qiang B, Gu D. Renalase gene is a novel susceptibility gene for essential hypertension: A two-stage association study in northern han chinese population. J Mol Med (Berl) 2007; 85: 877-885
6. Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (glu37asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: Data from the heart and soul study. PLoS One 2010; 5: e13496
7. Wu Y, Xu J, Velazquez H, Wang P, Li G, Liu D, Sampaio-Maia B, Quelhas-Santos J, Russell K, Russell R, Flavell RA, Pestana M, Giordano F, Desir GV. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int 2011; 79: 853-860
8. Baraka A, El Ghotny S. Cardioprotective effect of renalase in 5/6 nephrectomized rats. J Cardiovasc Pharmacol Ther 2012; 17: 412-416
9. Ptinopoulou AG, Pikilidou MI, Lasaridis AN. The effect of antihypertensive drugs on chronic kidney disease: A comprehensive review. Hypertens Res 2013; 36: 91-101
10. Blankestijn PJ, London G, Fliser D, Jager KJ, Lindholm B, Goldsmith D, Wiecek A, Suleymanlar G, Agarwal R, Ortiz A. Major pathways of the reno-cardiovascular link: The sympathetic and renin-Angiotensin systems. Kidney Int Suppl 2011; 1: 13-16
11. Kramer AB, van Timmeren MM, Schuurs TA, Vaidya VS, Bonventre JV, van Goor H, Navis G. Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (kim-1) over time. Am J Physiol Renal Physiol 2009; 296: F1136-1145
12. Tang SC, Leung JC, Chan LY, Eddy AA, Lai KN. Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy. Kidney Int 2008; 73: 288-299
13. Kramer AB, van der Meulen EF, Hamming I, van Goor H, Navis G. Effect of combining ace inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kidney Int 2007; 71: 417-424
14. Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clin Sci (Lond) 1996; 90: 393-401
15. Scholey JW, Miller PL, Rennke HG, Meyer TW. Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy. Kidney Int 1989; 36: 816-822
16. Sun HL, Sun L, Li YY, Shao MM, Cheng XY, Ge N, Lu JD, Li SM. Ace-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats. Exp Clin Endocrinol Diabetes 2009; 117: 336-344
17. Sun H, Ge N, Shao M, Cheng X, Li Y, Li S, Shen J. Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2013; 100: 85-95
18. Gu R, Lu W, Xie J, Bai J, Xu B. Renalase deficiency in heart failure model of rats-A potential mechanism underlying circulating norepinephrine accumulation. PLoS One 2011; 6: e14633
19. Desir GV. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens 2008; 17: 181-185
20. Milani M, Ciriello F, Baroni S, Pandini V, Canevari G, Bolognesi M, Aliverti A. Fad-binding site and nadp reactivity in human renalase: A new enzyme involved in blood pressure regulation. J Mol Biol 2011; 411: 463-473
21. Desir G. Novel insights into the physiology of renalase and its role in hypertension and heart disease. Pediatr Nephrol 2012; 27: 719-725
22. Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int 2009; 76: 366-370
23. Wang F, Wang N-s, Xing T, Cao Y, Xiang H-y: The cloning and expression of renalase and the preparation of its monoclonal antibody. J Shanghai Jiaotong Univ (Sci) 2009; 14: 376-379
24. Desir GV, Wang L, Peixoto AJ. Human renalase: A review of its biology, function, and implications for hypertension. J Am Soc Hypertens 2012; 6: 417-426
25. Quelhas-Santos J, Sampaio-Maia B, Simoes-Silva L, Serrao P, Fernandes-Cerqueira C, Soares-Silva I, Pestana M. Sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney. J Hypertens 2013; 31: 543-553
26. Malyszko J, Zbroch E, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc 2011; 43: 3004-3007
27. Przybylowski P, Malyszko J, Kozlowska S, Koc-Zorawska E, Mysliwiec M. Serum renalase depends on kidney function but not on blood pressure in heart transplant recipients. Transplant Proc 2011; 43: 3888-3891
28. Malyszko J, Koc-Zorawska E, Malyszko JS, Kozminski P, Zbroch E, Mysliwiec M. Renalase, stroke, and hypertension in hemodialyzed patients. Ren Fail 2012; 34: 727-731
29. Zbroch E, Malyszko J, Koc-Zorawska E, Mysliwiec M. Renalase in peritoneal dialysis patients is not related to blood pressure, but to dialysis vintage. Perit Dial Int 2012; 32: 348-351
30. Zbroch E, Malyszko J, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel enzyme involved in blood pressure regulation, is related to kidney function but not to blood pressure in hemodialysis patients. Kidney Blood Press Res 2012; 35: 395-399
31. Lee HT, Kim JY, Kim M, Wang P, Tang L, Baroni S, D'Agati VD, Desir GV. Renalase protects against ischemic aki. J Am Soc Nephrol 2013; 24: 445-455